TOP 100 MEDICAL SITES
| |||
|
| |||
| |||
|
| |||
| Medtech Brings in Life Sciences Venture Dollars The Burrill Report submits: By Marie Daghlian A couple of medical device companies closed significant financing rounds during a week when many members of the biotech community were wheeling and dealing in Chicago at the annual BIO International Convention. Atlanta-based CardioMEMS completed a $37.9 million financing that came from Arcapita Ventures and other existing investors. CardioMems is a digital health company developing wireless patient monitoring technology. The company will use the capital to complete its 550 patient CHAMPION clinical trial evaluating the safety and effectiveness of its heart failure pressure measurement system. Results are expected this summer. CardioMEMS’ miniature sensor device is implanted in the patient’s pulmonary artery in a catheter-based procedure. The pulmonary artery pressure is then measured and displayed using an electronic monitoring system. The procedure allows patients to perform wireless measurements of their pulmonary artery pressure from home. Data is transmitted to a secure database and is available for review by the implanting physician on the CardioMEMS proprietary website. Complete Story » seekingalpha.com |
Nu Skin Keep Your Age a Mystery Contest - Video NU SKIN LAUNCHES GLOBAL CONTEST TO IDENTIFY NEW 'FRESH FACES' OF AGELOC feedproxy.google.com |
Ironwood Pharmaceuticals Announces Upcoming Presentation at Wedbush Life Sciences MAC Best Ideas 2010 (Business Wire) CAMBRIDGE, Mass.----Ironwood Pharmaceuticals, Inc. today announced that Michael Higgins, Ironwood’s chief financial officer and chief operating officer, will present at Wedbush Life Sciences MAC Best Ideas 2010 on Tuesday, August 3, 2010 at 8:35 a.m. us.rd.yahoo.com |
Lawmakers to Question Egg-Farm Executives Lawmakers on Wednesday will question executives from the companies involved in the summer egg recall, while consumer advocates lobby for tougher food-safety regulations. online.wsj.com |
Tengion Announces Webcast of Analyst and Investor Meeting on October 27, 2010 [PR Newswire] - Tengion, Inc. , a leader in regenerative medicine, today announced that it will host an Analyst and Investor Meeting on Wednesday, October 27, 2010 in New York, New York. Tengion's management team will provide an update on the Company's product development portfolio and upcoming corporate milestones, and will expand on recently presented data from the Neo-Kidney Augmentâ„¢ program. us.rd.yahoo.com |